Logo image of ACON

ACLARION INC (ACON) Stock Fundamental Analysis

NASDAQ:ACON - Nasdaq - US6551874091 - Common Stock - Currency: USD

7.135  -0.57 (-7.38%)

Fundamental Rating

3

Overall ACON gets a fundamental rating of 3 out of 10. We evaluated ACON against 35 industry peers in the Health Care Technology industry. ACON has a great financial health rating, but its profitability evaluates not so good. ACON is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ACON had negative earnings in the past year.
ACON had a negative operating cash flow in the past year.
In the past 5 years ACON always reported negative net income.
In the past 5 years ACON always reported negative operating cash flow.
ACON Yearly Net Income VS EBIT VS OCF VS FCFACON Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -2M -4M -6M

1.2 Ratios

ACON has a Return On Assets of -40.64%. This is in the lower half of the industry: ACON underperforms 71.43% of its industry peers.
ACON has a Return On Equity (-42.44%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -40.64%
ROE -42.44%
ROIC N/A
ROA(3y)-263.04%
ROA(5y)-305.81%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ACON Yearly ROA, ROE, ROICACON Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 500 -500

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ACON so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ACON Yearly Profit, Operating, Gross MarginsACON Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 -5K -10K -15K

More info and screens

7

2. Health

2.1 Basic Checks

ACON does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ACON has been increased compared to 1 year ago.
ACON has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ACON Yearly Shares OutstandingACON Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2M 4M 6M
ACON Yearly Total Debt VS Total AssetsACON Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M

2.2 Solvency

ACON has an Altman-Z score of -0.78. This is a bad value and indicates that ACON is not financially healthy and even has some risk of bankruptcy.
ACON has a Altman-Z score of -0.78. This is in the lower half of the industry: ACON underperforms 60.00% of its industry peers.
There is no outstanding debt for ACON. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -0.78
ROIC/WACCN/A
WACC9.69%
ACON Yearly LT Debt VS Equity VS FCFACON Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 2M -2M -4M -6M

2.3 Liquidity

ACON has a Current Ratio of 21.68. This indicates that ACON is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of ACON (21.68) is better than 100.00% of its industry peers.
ACON has a Quick Ratio of 21.68. This indicates that ACON is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of ACON (21.68) is better than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 21.68
Quick Ratio 21.68
ACON Yearly Current Assets VS Current LiabilitesACON Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2M 4M 6M 8M

More info and screens

4

3. Growth

3.1 Past

ACON shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 93.40%, which is quite impressive.
Looking at the last year, ACON shows a decrease in Revenue. The Revenue has decreased by -9.15% in the last year.
ACON shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -8.83% yearly.
EPS 1Y (TTM)93.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.77%
Revenue 1Y (TTM)-9.15%
Revenue growth 3Y-8.83%
Revenue growth 5YN/A
Sales Q2Q%89.9%

3.2 Future

Based on estimates for the next years, ACON will show a very strong growth in Earnings Per Share. The EPS will grow by 41.36% on average per year.
ACON is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 121.56% yearly.
EPS Next Y99.81%
EPS Next 2Y41.36%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year100%
Revenue Next 2Y121.57%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ACON Yearly Revenue VS EstimatesACON Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 100K 200K 300K
ACON Yearly EPS VS EstimatesACON Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 -100K -200K -300K

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ACON. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ACON. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ACON Price Earnings VS Forward Price EarningsACON Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ACON Per share dataACON EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1K -2K -3K

4.3 Compensation for Growth

A more expensive valuation may be justified as ACON's earnings are expected to grow with 41.36% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.36%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ACON does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ACLARION INC

NASDAQ:ACON (7/30/2025, 8:00:00 PM)

7.135

-0.57 (-7.38%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)05-15 2025-05-15/bmo
Earnings (Next)N/A N/A
Inst Owners0.08%
Inst Owner Change0%
Ins Owners0%
Ins Owner Change0%
Market Cap4.14M
Analysts82.86
Price Target20.4 (185.91%)
Short Float %2.75%
Short Ratio1.05
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)65.58%
Min EPS beat(2)31.78%
Max EPS beat(2)99.37%
EPS beat(4)4
Avg EPS beat(4)41.81%
Min EPS beat(4)13.49%
Max EPS beat(4)99.37%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-38.16%
Min Revenue beat(2)-38.38%
Max Revenue beat(2)-37.94%
Revenue beat(4)0
Avg Revenue beat(4)-44.6%
Min Revenue beat(4)-56.98%
Max Revenue beat(4)-37.94%
Revenue beat(8)0
Avg Revenue beat(8)-57.06%
Revenue beat(12)2
Avg Revenue beat(12)-36.2%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-99.83%
PT rev (3m)-99.83%
EPS NQ rev (1m)99.83%
EPS NQ rev (3m)99.72%
EPS NY rev (1m)99.76%
EPS NY rev (3m)99.76%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-21.43%
Revenue NY rev (3m)-21.43%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 75.79
P/FCF N/A
P/OCF N/A
P/B 0.26
P/tB 0.29
EV/EBITDA N/A
EPS(TTM)-3509.52
EYN/A
EPS(NY)-12.37
Fwd EYN/A
FCF(TTM)-10.14
FCFYN/A
OCF(TTM)-9.56
OCFYN/A
SpS0.09
BVpS27.21
TBVpS24.94
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -40.64%
ROE -42.44%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-263.04%
ROA(5y)-305.81%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 165.6%
Cap/Sales 616.3%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 21.68
Quick Ratio 21.68
Altman-Z -0.78
F-Score4
WACC9.69%
ROIC/WACCN/A
Cap/Depr(3y)128.54%
Cap/Depr(5y)106.31%
Cap/Sales(3y)402.91%
Cap/Sales(5y)349.24%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)93.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.77%
EPS Next Y99.81%
EPS Next 2Y41.36%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-9.15%
Revenue growth 3Y-8.83%
Revenue growth 5YN/A
Sales Q2Q%89.9%
Revenue Next Year100%
Revenue Next 2Y121.57%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-15.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1.55%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y2.79%
OCF growth 3YN/A
OCF growth 5YN/A